These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Significance of anti-carbamylated fibrinogen antibodies in systemic lupus erythematosus].
    Author: Li YN, Xiang XH, Zhao J, Li Y, Sun F, Wang HY, Jia RL, Hu FL.
    Journal: Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec 18; 51(6):1019-1024. PubMed ID: 31848497.
    Abstract:
    OBJECTIVE: Antibodies against carbamylated protein (anti-CarP) were found to be a promising marker to evaluate joint damage and disease activity in patients with rheumatoid arthritis (RA). However, whether anti-CarP antibodies were present in systemic lupus erythematosus (SLE) remained ambiguity. We have therefore undertaken this study to assess the levels of serum anti-CarP antibodies and to evaluate their clinical value in SLE. METHODS: Serum levels of antibodies against carbamylatedfibrinogen (anti-CarP) were measured by enzyme-linked immunosorbent assay (ELISA) in 105 SLE patients and 73 healthy controls. Other clinical and laboratory measurements of the SLE patients were collected from medical records. Data analyses between anti-CarP antibodies and other laboratory measurements were performed using SPSS software for Windows 24.0. RESULTS: The levels of serum anti-CarP antibodies in the patients with SLE were significantly higher than those in the healthy controls (P<0.05). There were significant differences between the anti-CarP-positive group and anti-CarP-negative group in many clinical features. The disease duration, values of ESR, CRP, RF, anti-cardiolipin, anti-dsDNA, D-dipolymer, IgA and IgG were significantly higher in the anti-CarP-positive group compared with the negative group (P<0.05). Conversely, the values of complement 3, complement 4, peripheral blood RBC, and hemoglobin were significantly lower in anti-CarP-positive group than in the negative group(P<0.05). Moreover, the incidence of increase of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), D-dipolymer, decrease of peripheral blood RBC, hemoglobin, complement 3, complement 4, and positive rate of anti-dsDNA were significant different between the two groups(P<0.05). The positive rate of anti-CarP (21.9%) was higher than that of anti-Sm (15.24%), and close to anti-ribosomal P protein (22.86%) in our SLE patients. In addition, anti-CarP antibody was present in the SLE patients lacking the disease specific antibodies, including anti-Sm (anti-CarP positive rate 20.2%, 18/89), anti-dsDNA (anti-CarP positive rate 9.3%, 4/43), anti-nucleosome (anti-CarP positive rate 12.5%, 6/48), and anti-ribosomal P protein antibody (anti-CarP positive rate 20.9%, 17/81). Moreover, the high levels of anti-CarP antibodies were correlated with short disease duration, low C3, C4, RBC, and hemoglobin (P<0.05), high ESR, CRP, IgA, IgG, RF, anti-cardiolipin, anti-dsDNA, and D-dipolymer (P<0.05). CONCLUSION: The level of anti-CarP antibody was increased in the serum of patients with SLE. There were correlations between anti-CarP antibodies and clinical and laboratory indicators of SLE patients. 目的: 探讨抗类瓜氨酸化抗体(anti-carbamylated fibrinogen antibodies, 抗CarP抗体)在系统性红斑狼疮(systemic lupus erythematosus,SLE)中的意义,SLE是否与类风湿关节炎(rheumatoid arthritis, RA)一样,存在大量针对类瓜氨酸的自身抗体,抗CarP抗体与关节损伤及疾病活动度高度相关。 方法: 利用酶联免疫吸附法(enzyme-linked immunosorbent assay,ELISA)检测105例确诊的SLE患者和73例健康对照者血清中抗CarP抗体水平,收集其他SLE相关临床和实验室数据,采用SPSS 24.0软件进行相应统计学分析。 结果: SLE中存在抗CarP抗体,且明显高于健康对照组(P<0.05)。抗CarP抗体阳性组与阴性组SLE患者相比,在以下临床及实验室指标方面差异有统计学意义:病程、血沉(erythrocyte sedimentation rate,ESR)、C-反应蛋白(C-reactive protein,CRP)、类风湿因子(rheumatoid factor,RF)、抗心磷脂抗体、抗dsDNA抗体、D-二聚体、IgA、IgG、补体C3、补体C4、外周血红细胞计数和血红蛋白水平(P<0.05)。与SLE其他自身抗体相比,抗CarP抗体的阳性率(21.9%)高于抗Sm抗体(15.24%),与抗核糖体P蛋白抗体(22.86%)阳性率相似;在SLE特异性抗体阴性的患者中可检测到抗CarP抗体,其阳性率分别为: 抗Sm(-)组20.2%(18/89),抗dsDNA(-)组9.3%(4/43),抗核小体抗体(-)组12.5%(6/48)和抗核糖体P蛋白抗体(-)组20.9%(17/81)。而且,抗CarP抗体水平与病程、补体C3、补体C4、红细胞及血红蛋白呈明显负相关(P<0.05),与ESR、CRP、IgA、IgG、RF、抗心磷脂抗体、抗dsDNA抗体及D-二聚体呈明显正相关(P<0.05)。 结论: SLE患者血清中抗CarP抗体水平升高,抗CarP抗体与SLE患者临床及实验室指标具有相关性。
    [Abstract] [Full Text] [Related] [New Search]